Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:41 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alfavision Overseas (India) Ltd reported a steep decline in revenue, with sales figures standing at ₹58.58 Cr for the financial year ending March 2023, a significant drop from ₹181.57 Cr in March 2022. This downward trend is stark when compared to the previous years, where sales had been on a relatively stable upward trajectory, peaking at ₹179.10 Cr in March 2021. The quarterly sales data reveals volatility, with the company experiencing negative sales of ₹1.74 Cr in March 2023, following a series of inconsistent quarterly performances. For instance, sales in December 2022 were ₹44.42 Cr, which showed a recovery from a low of ₹14.84 Cr in September 2022, but this recovery was not sustained. The company’s sales history indicates challenges in maintaining consistent revenue streams, which could be attributed to operational inefficiencies or market dynamics that require further investigation.
Profitability and Efficiency Metrics
The profitability metrics for Alfavision Overseas reflect a concerning trend, with a reported net profit of -₹2.16 Cr for the financial year ending March 2023. This marks a stark decline from ₹2.01 Cr in March 2022 and ₹1.49 Cr in March 2021. The company’s operating profit margin (OPM) improved slightly to 4.54% in March 2023 from 2.72% in March 2022, indicating some operational efficiency gains, but this was overshadowed by the overall negative profitability. The interest coverage ratio stood at 0.55x, a significant decline from 1.55x in March 2022, signalling challenges in covering interest expenses. The return on equity (ROE) was recorded at 5.22%, which is low compared to industry standards, suggesting that shareholder returns are not being maximized effectively. Overall, while there are signs of operational improvement, the company’s profitability remains under significant pressure.
Balance Sheet Strength and Financial Ratios
Alfavision’s balance sheet reflects a precarious financial position, with no reported reserves or borrowings, indicating a lack of financial buffers. The company’s price-to-book value ratio (P/BV) stood at 1.53x, suggesting that the stock is trading above its book value, which could be a concern for investors. The company’s total debt-to-equity ratio is exceptionally high at 3.62x, indicating that it is heavily leveraged, which poses risks in a rising interest rate environment. The current and quick ratios are both reported at 1.06x, suggesting that the company has just enough current assets to cover its current liabilities. However, this liquidity position is lower than typical sector benchmarks, which often exceed 1.5x, highlighting potential liquidity risks. Overall, the financial ratios indicate that while the company is not facing immediate solvency issues, its leverage and lack of reserves could pose significant risks if operational performance does not improve.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alfavision Overseas shows a stable yet concerning structure, with promoters holding 24.80% and the public holding 75.19% as of March 2023. The number of shareholders has decreased from 3,294 in December 2022 to 3,249 in March 2023, suggesting a potential decline in investor confidence. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) further underscores the lack of institutional support, which could impact stock performance and market perception. The dividend payout ratio for March 2023 was reported at -7.57%, indicating that the company is not distributing profits to shareholders, which typically raises red flags for investor sentiment. Overall, while the promoter stake remains stable, the lack of institutional backing and declining shareholder numbers could signal a waning interest in the company’s future prospects.
Outlook, Risks, and Final Insight
The outlook for Alfavision Overseas hinges on its ability to stabilize and improve operational performance amidst significant challenges. Key strengths include a manageable liquidity position indicated by a current ratio of 1.06x and a slight improvement in operational profit margins. However, risks are pronounced with the company facing declining revenues, negative profitability, and high leverage ratios. If the company can capitalize on operational efficiencies and regain market share, it may see a reversal in fortunes. Conversely, failure to address these operational and financial challenges could lead to further declines in shareholder value and market confidence. As such, stakeholders should closely monitor operational performance and financial health in the upcoming quarters to gauge the company’s trajectory in a competitive market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alfavision Overseas (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 107 Cr. | 27.4 | 832/26.8 | 1.04 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,792 Cr. | 177 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 49.5 Cr. | 3.88 | 8.65/3.55 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,995.68 Cr | 225.62 | 433.91 | 219.29 | 0.24% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 105.36 | 25.84 | 48.62 | 48.21 | 56.43 | 1.06 | 53.72 | 44.42 | 53.72 | 44.42 | 14.84 | 44.42 | -1.74 |
| Expenses | 102.93 | 25.85 | 48.48 | 46.73 | 54.52 | 0.66 | 52.67 | 42.89 | 52.67 | 42.89 | 12.47 | 42.89 | 0.12 |
| Operating Profit | 2.43 | -0.01 | 0.14 | 1.48 | 1.91 | 0.40 | 1.05 | 1.53 | 1.05 | 1.53 | 2.37 | 1.53 | -1.86 |
| OPM % | 2.31% | -0.04% | 0.29% | 3.07% | 3.38% | 37.74% | 1.95% | 3.44% | 1.95% | 3.44% | 15.97% | 3.44% | |
| Other Income | -0.08 | 0.73 | 0.23 | 0.23 | 0.23 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 2.16 | 0.68 | 0.31 | 1.32 | 0.84 | 0.60 | 0.61 | 1.07 | 0.61 | 1.07 | 1.16 | 1.07 | 1.32 |
| Depreciation | -0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.00 | 0.03 | 0.00 | 0.03 | 0.00 | 0.03 | 0.02 |
| Profit before tax | 0.21 | 0.02 | 0.03 | 0.36 | 1.28 | 0.02 | 0.44 | 0.43 | 0.44 | 0.43 | 1.21 | 0.43 | -3.19 |
| Tax % | 42.86% | 0.00% | 33.33% | 0.00% | 20.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.31% |
| Net Profit | 0.13 | 0.02 | 0.02 | 0.37 | 1.01 | 0.03 | 0.44 | 0.44 | 0.44 | 0.44 | 1.21 | 0.44 | -3.20 |
| EPS in Rs | 0.04 | 0.01 | 0.01 | 0.12 | 0.32 | 0.01 | 0.14 | 0.14 | 0.14 | 0.14 | 0.38 | 0.14 | -1.02 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Alfavision Overseas (India) Ltd based on the most recent figures (Mar 2023) and their trends compared to the previous period:
- For Sales, as of Mar 2023, the value is -1.74 Cr.. The value appears to be declining and may need further review. It has decreased from 44.42 Cr. (Dec 2022) to -1.74 Cr., marking a decrease of 46.16 Cr..
- For Expenses, as of Mar 2023, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.89 Cr. (Dec 2022) to 0.12 Cr., marking a decrease of 42.77 Cr..
- For Operating Profit, as of Mar 2023, the value is -1.86 Cr.. The value appears to be declining and may need further review. It has decreased from 1.53 Cr. (Dec 2022) to -1.86 Cr., marking a decrease of 3.39 Cr..
- For OPM %, as of Mar 2023, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 3.44% (Dec 2022) to 0.00%, marking a decrease of 3.44%.
- For Other Income, as of Mar 2023, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2022) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Mar 2023, the value is 1.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.07 Cr. (Dec 2022) to 1.32 Cr., marking an increase of 0.25 Cr..
- For Depreciation, as of Mar 2023, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Dec 2022) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Mar 2023, the value is -3.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Dec 2022) to -3.19 Cr., marking a decrease of 3.62 Cr..
- For Tax %, as of Mar 2023, the value is 0.31%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2022) to 0.31%, marking an increase of 0.31%.
- For Net Profit, as of Mar 2023, the value is -3.20 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Dec 2022) to -3.20 Cr., marking a decrease of 3.64 Cr..
- For EPS in Rs, as of Mar 2023, the value is -1.02. The value appears to be declining and may need further review. It has decreased from 0.14 (Dec 2022) to -1.02, marking a decrease of 1.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Sales | 98.59 | 116.45 | 156.98 | 179.10 | 181.57 | 58.58 |
| Expenses | 96.66 | 114.06 | 153.65 | 175.04 | 176.64 | 55.92 |
| Operating Profit | 1.93 | 2.39 | 3.33 | 4.06 | 4.93 | 2.66 |
| OPM % | 1.96% | 2.05% | 2.12% | 2.27% | 2.72% | 4.54% |
| Other Income | 0.19 | 0.10 | 0.00 | 0.92 | 1.23 | 0.01 |
| Interest | 1.76 | 2.16 | 2.98 | 3.19 | 3.98 | 4.77 |
| Depreciation | 0.17 | 0.18 | 0.09 | 0.10 | 0.10 | 0.05 |
| Profit before tax | 0.19 | 0.15 | 0.26 | 1.69 | 2.08 | -2.15 |
| Tax % | -10.53% | -20.00% | 34.62% | 12.43% | 3.37% | 0.47% |
| Net Profit | 0.22 | 0.18 | 0.17 | 1.49 | 2.01 | -2.16 |
| EPS in Rs | 0.07 | 0.06 | 0.05 | 0.47 | 0.64 | -0.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 4.23% | 7.84% | 0.00% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -5.56% | 776.47% | 34.90% | -207.46% |
| Change in YoY Net Profit Growth (%) | 0.00% | 12.63% | 782.03% | -741.57% | -242.36% |
Alfavision Overseas (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2018-2019 to 2022-2023.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -10% |
| 3 Years: | -28% |
| TTM: | -68% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -207% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 23% |
| 3 Years: | -42% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:11 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
No data available for the Financial Efficiency data table.
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -6.87 | 6.38 | 0.45 | 0.53 | 0.57 |
| Diluted EPS (Rs.) | -6.87 | 6.38 | 0.45 | 0.53 | 0.57 |
| Cash EPS (Rs.) | -0.34 | 6.70 | 4.87 | 0.81 | 1.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.99 | 144.65 | 42.70 | 38.15 | 31.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.99 | 144.65 | 42.70 | 38.15 | 31.71 |
| Revenue From Operations / Share (Rs.) | 9.46 | 575.94 | 568.10 | 497.94 | 369.39 |
| PBDIT / Share (Rs.) | 0.42 | 19.54 | 15.65 | 10.57 | 7.91 |
| PBIT / Share (Rs.) | 0.41 | 19.23 | 15.34 | 10.29 | 7.33 |
| PBT / Share (Rs.) | -0.34 | 6.59 | 5.37 | 0.82 | 0.47 |
| Net Profit / Share (Rs.) | -0.34 | 6.38 | 4.55 | 0.53 | 0.50 |
| NP After MI And SOA / Share (Rs.) | -0.34 | 6.38 | 4.55 | 0.53 | 0.50 |
| PBDIT Margin (%) | 4.50 | 3.39 | 2.75 | 2.12 | 2.14 |
| PBIT Margin (%) | 4.42 | 3.33 | 2.69 | 2.06 | 1.98 |
| PBT Margin (%) | -3.67 | 1.14 | 0.94 | 0.16 | 0.12 |
| Net Profit Margin (%) | -3.69 | 1.10 | 0.80 | 0.10 | 0.13 |
| NP After MI And SOA Margin (%) | -3.69 | 1.10 | 0.80 | 0.10 | 0.13 |
| Return on Networth / Equity (%) | -5.00 | 4.41 | 14.58 | 1.99 | 1.92 |
| Return on Capital Employeed (%) | 1.29 | 3.46 | 13.10 | 10.12 | 15.33 |
| Return On Assets (%) | -1.05 | 0.63 | 1.23 | 0.16 | 0.25 |
| Long Term Debt / Equity (X) | 3.62 | 2.83 | 2.38 | 2.36 | 0.61 |
| Total Debt / Equity (X) | 3.62 | 3.14 | 5.56 | 5.81 | 3.54 |
| Asset Turnover Ratio (%) | 0.22 | 0.49 | 1.04 | 1.13 | 1.41 |
| Current Ratio (X) | 1.06 | 1.28 | 1.27 | 1.24 | 1.30 |
| Quick Ratio (X) | 1.06 | 1.28 | 1.26 | 1.24 | 1.30 |
| Dividend Payout Ratio (NP) (%) | -7.57 | 3.13 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | -7.74 | 2.98 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 107.57 | 96.87 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 107.74 | 97.02 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.55 | 1.55 | 1.57 | 1.12 | 1.15 |
| Interest Coverage Ratio (Post Tax) (X) | 0.54 | 1.51 | 1.46 | 1.06 | 1.07 |
| Enterprise Value (Cr.) | 222.71 | 183.17 | 70.22 | 60.10 | 41.62 |
| EV / Net Operating Revenue (X) | 3.80 | 1.01 | 0.39 | 0.38 | 0.35 |
| EV / EBITDA (X) | 84.39 | 29.73 | 14.23 | 18.03 | 16.68 |
| MarketCap / Net Operating Revenue (X) | 1.13 | 0.22 | 0.06 | 0.05 | 0.09 |
| Retention Ratios (%) | 107.57 | 96.86 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.53 | 0.89 | 1.23 | 0.94 | 1.32 |
| Price / Net Operating Revenue (X) | 1.13 | 0.22 | 0.06 | 0.05 | 0.09 |
| EarningsYield | -0.03 | 0.04 | 0.11 | 0.02 | 0.01 |
After reviewing the key financial ratios for Alfavision Overseas (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 22) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 23, the value is -6.87. This value is below the healthy minimum of 5. It has decreased from 6.38 (Mar 22) to -6.87, marking a decrease of 13.25.
- For Diluted EPS (Rs.), as of Mar 23, the value is -6.87. This value is below the healthy minimum of 5. It has decreased from 6.38 (Mar 22) to -6.87, marking a decrease of 13.25.
- For Cash EPS (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 3. It has decreased from 6.70 (Mar 22) to -0.34, marking a decrease of 7.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 6.99. It has decreased from 144.65 (Mar 22) to 6.99, marking a decrease of 137.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 6.99. It has decreased from 144.65 (Mar 22) to 6.99, marking a decrease of 137.66.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 9.46. It has decreased from 575.94 (Mar 22) to 9.46, marking a decrease of 566.48.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 0.42. This value is below the healthy minimum of 2. It has decreased from 19.54 (Mar 22) to 0.42, marking a decrease of 19.12.
- For PBIT / Share (Rs.), as of Mar 23, the value is 0.41. This value is within the healthy range. It has decreased from 19.23 (Mar 22) to 0.41, marking a decrease of 18.82.
- For PBT / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 0. It has decreased from 6.59 (Mar 22) to -0.34, marking a decrease of 6.93.
- For Net Profit / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 2. It has decreased from 6.38 (Mar 22) to -0.34, marking a decrease of 6.72.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 2. It has decreased from 6.38 (Mar 22) to -0.34, marking a decrease of 6.72.
- For PBDIT Margin (%), as of Mar 23, the value is 4.50. This value is below the healthy minimum of 10. It has increased from 3.39 (Mar 22) to 4.50, marking an increase of 1.11.
- For PBIT Margin (%), as of Mar 23, the value is 4.42. This value is below the healthy minimum of 10. It has increased from 3.33 (Mar 22) to 4.42, marking an increase of 1.09.
- For PBT Margin (%), as of Mar 23, the value is -3.67. This value is below the healthy minimum of 10. It has decreased from 1.14 (Mar 22) to -3.67, marking a decrease of 4.81.
- For Net Profit Margin (%), as of Mar 23, the value is -3.69. This value is below the healthy minimum of 5. It has decreased from 1.10 (Mar 22) to -3.69, marking a decrease of 4.79.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is -3.69. This value is below the healthy minimum of 8. It has decreased from 1.10 (Mar 22) to -3.69, marking a decrease of 4.79.
- For Return on Networth / Equity (%), as of Mar 23, the value is -5.00. This value is below the healthy minimum of 15. It has decreased from 4.41 (Mar 22) to -5.00, marking a decrease of 9.41.
- For Return on Capital Employeed (%), as of Mar 23, the value is 1.29. This value is below the healthy minimum of 10. It has decreased from 3.46 (Mar 22) to 1.29, marking a decrease of 2.17.
- For Return On Assets (%), as of Mar 23, the value is -1.05. This value is below the healthy minimum of 5. It has decreased from 0.63 (Mar 22) to -1.05, marking a decrease of 1.68.
- For Long Term Debt / Equity (X), as of Mar 23, the value is 3.62. This value exceeds the healthy maximum of 1. It has increased from 2.83 (Mar 22) to 3.62, marking an increase of 0.79.
- For Total Debt / Equity (X), as of Mar 23, the value is 3.62. This value exceeds the healthy maximum of 1. It has increased from 3.14 (Mar 22) to 3.62, marking an increase of 0.48.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.22. It has decreased from 0.49 (Mar 22) to 0.22, marking a decrease of 0.27.
- For Current Ratio (X), as of Mar 23, the value is 1.06. This value is below the healthy minimum of 1.5. It has decreased from 1.28 (Mar 22) to 1.06, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 23, the value is 1.06. This value is within the healthy range. It has decreased from 1.28 (Mar 22) to 1.06, marking a decrease of 0.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is -7.57. This value is below the healthy minimum of 20. It has decreased from 3.13 (Mar 22) to -7.57, marking a decrease of 10.70.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is -7.74. This value is below the healthy minimum of 20. It has decreased from 2.98 (Mar 22) to -7.74, marking a decrease of 10.72.
- For Earning Retention Ratio (%), as of Mar 23, the value is 107.57. This value exceeds the healthy maximum of 70. It has increased from 96.87 (Mar 22) to 107.57, marking an increase of 10.70.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 107.74. This value exceeds the healthy maximum of 70. It has increased from 97.02 (Mar 22) to 107.74, marking an increase of 10.72.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 0.55. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 22) to 0.55, marking a decrease of 1.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 0.54. This value is below the healthy minimum of 3. It has decreased from 1.51 (Mar 22) to 0.54, marking a decrease of 0.97.
- For Enterprise Value (Cr.), as of Mar 23, the value is 222.71. It has increased from 183.17 (Mar 22) to 222.71, marking an increase of 39.54.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 3.80. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 22) to 3.80, marking an increase of 2.79.
- For EV / EBITDA (X), as of Mar 23, the value is 84.39. This value exceeds the healthy maximum of 15. It has increased from 29.73 (Mar 22) to 84.39, marking an increase of 54.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 1.13. This value is within the healthy range. It has increased from 0.22 (Mar 22) to 1.13, marking an increase of 0.91.
- For Retention Ratios (%), as of Mar 23, the value is 107.57. This value exceeds the healthy maximum of 70. It has increased from 96.86 (Mar 22) to 107.57, marking an increase of 10.71.
- For Price / BV (X), as of Mar 23, the value is 1.53. This value is within the healthy range. It has increased from 0.89 (Mar 22) to 1.53, marking an increase of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 1.13. This value is within the healthy range. It has increased from 0.22 (Mar 22) to 1.13, marking an increase of 0.91.
- For EarningsYield, as of Mar 23, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 22) to -0.03, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alfavision Overseas (India) Ltd:
- Net Profit Margin: -3.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.29% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 433.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.62
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.69%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 135, Old Gauri Nagar Indore Madhya Pradesh 452010 | alfavision@rediffmail.com www.alfavisionoverseasindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vishnu Prasad Goyal | Chairman & Managing Director |
| Mr. Ravi Goyal | Non Executive Director & CFO |
| Mrs. Niharika Roongta | Ind. Non-Executive Director |